Skip to main content
. 2002 Jun 15;22(12):5198–5203. doi: 10.1523/JNEUROSCI.22-12-05198.2002

Table 2.

Disease severity of PD patients (n = 23)

Duration (years) l-dopa daily dose (mg)2-a H&Y UPDRS total score
3.5 ± 2.2 (1–8) 296 ± 150 (0–600) 2.1 ± 0.7 (1–3) 23.4 ± 8.5 (8–41)

Mean ± SD (range).

F2-a

l-dopa was prescribed in combination with peripheral decarboxylase inhibitors.